[1] Wakesman SA, Heriei AT. The nomen culture and classification of the Actinoymcetes[J]. J Bacteriol, 1943, 46:337-341.
[2] Kieser HM, Kieser T, Hopwood DA. A combined genetic and physi-cal map of the Streptomyces coelicolor A3(2)chromosome[J]. J Bacteriol, 1992, 174:5496-5507.
[3] Goodfellow M, Cross T. The Biology of the Actinomyces[M]. London:Academic Press, 1984.
[4] Franco CM, Coutinho LE. Detection of novel secondary metabolites[J]. Crit Rev Biotechnol, 1991, 11:193-276.
[5] Davies J. What are antibiotics? Archaic functions for modern activities[J]. Mol Microbiol, 1990, 4:1227-1232.
[6] Morin RB, Gorman M. Chemistry and biology of beta-lactam antibiotics[M]. New York:Academic Press, 1982.
[7] Strynadka NC, Adachi H, Jensen SE, et al. Molecular structure of the acyl-enzyme intermediate in beta-lactam hydrolysis at 1. 7 A resolution[J]. Nature, 1992, 359:700-705.
[8]Arai M. Azalomycins B and F, two new antibiotics. I. Production and isolation[J]. The Journal of Antibiotics, 1960, 13:46.
[9]Krystofova S, Varecka L, Betina V. The uptake by trichoderma viride Mycelium. correlation with growth and conidiation[J]. General Physiology and Biophysics, 1995, 14:323-338.
[10] Yuan G, Hong K, Lin H, et al. New azalomycin F analogs from ma-ngrove Streptomyces sp. 211726 with activity against microbes and cancer cells[J]. Marine Drugs, 2013, 11:817-829.
[11] Yuan G, Lin H, Wang C, et al. 1H and 13C assignments of two new macrocyclic lactones isolated from Streptomyces sp. 211726 and revised assignments of azalomycins F3a, F4a and F5a[J]. Magnetic Resonance in Chemistry:MRC, 2011, 49:30-37.
[12] Yuan GJ, Hong K, Lin HP, Li J. Azalomycin F4a 2-ethylpentyl ester, a new macrocyclic lactone, from mangrove actinomycete Streptomyces sp. 211726[J]. Chinese Chemical Letters, 2010, 21:947-950.
[13]Yuan GJ, Li PB, Yang J, et al. Anti-methicillin-resistant Staphylococcus aureus assay of azalomycin F5a and its derivatives[J]. Chinese Journal of Natural Medicines, 2014, 12:309-313.
[14]Fukushima K, Arai T, Iwasaki S, et al. Studies on macrocyclic lactone antibiotics. VI. Skeletal structure of copiamycin[J]. J Antibiot(Tokyo), 1982, 35:1480-1494.
[15]袁干军. 产大环内酯化合物的红树林放线菌的筛选、产物分离鉴定及活性研究[D]. 海口:海南大学, 2010:1-185.
[16]Tobias K, Bibb MJ, Mark JB, et al. Practical Streptomyces Genetics[M]. Norwich:The John Innes Foundation, 2000.
[17]Mens T, Demeyer S, Du Bois B, et al. Refactoring:Current research and future trends[J]. Electronic Notes in Theoretical Computer Science, 2003, 82(3):483-499.
[18]Wilkinson CJ, Hughes-Thomas ZA, Martin CJ, et al. Increasing the efficiency of heterologous promoters in actinomycetes[J]. J Mol Microbiol Biotechnol, 2002, 4(4):417-426.
[19]Del Vecchio F, Petkovic H, Kendrew SG, et al. Active-site residue, domain and module swaps in modular polyketide synthases[J]. J Ind Microbiol Biotechnol, 2003, 30(8):489-494.
[20]Gerdes K, Rasmussen PB, Molin S. Unique type of plasmid maintenance function:postsegregational killing of plasmid-free cells[J]. Proceedings of the National Academy of Sciences, 1986, 83(10):3116-3120.
[21] Sun Y, He X, Liang J. Analysis of function in plasmid pHZ1358 influencing its genetic and structural stability in Streptomyces lividans 1326[J]. Applied Microbiology and Biotechnoogy, 2009, 82:303-310.
[22]Sun Y, Zhou X, Liu J, et al. Streptomyces nanchangensis, a producer of the insecticidal polyether antibiotic nanchangmycin and the antiparasitic macrolide meilingmycin, contains multiple polyketide gene clusters[J]. Microbiology, 2002, 148:361-371. |